Pearl, founded in 2019, developed the first FDA-cleared AI platform capable of reading and identifying diseases in dental X-rays.
The investment was led by the ADA’s Innovation Advisory Committee, which is dedicated to identifying and supporting solutions that elevate dentistry, according to a Dec. 17 news release.
